These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 17244121)

  • 21. Natriuretic peptides in ESRD.
    Joffy S; Rosner MH
    Am J Kidney Dis; 2005 Jul; 46(1):1-10. PubMed ID: 15983951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring risk in end-stage renal disease: is N-terminal pro brain natriuretic peptide a useful marker?
    Rosner MH
    Kidney Int; 2007 Mar; 71(6):481-3. PubMed ID: 17344896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relationship between B-type natriuretic peptide plasma level and left ventricular function in patients with chronic kidney disease on different type of treatment].
    Rasić S; Hadzovic-Dzuvo A; Rebić D; Dzemidzić J; Bilal F; Mataradzija A
    Acta Med Croatica; 2008; 62 Suppl 1():7-11. PubMed ID: 18578326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and prognostic impact of brain natriuretic peptide in cardiac and noncardiac diseases.
    Zakynthinos E; Kiropoulos T; Gourgoulianis K; Filippatos G
    Heart Lung; 2008; 37(4):275-85. PubMed ID: 18620103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility of natriuretic peptides in left ventricular failure.
    Reddy P; Samson R
    South Med J; 2013 Feb; 106(2):182-7. PubMed ID: 23380756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical status and B-type natriuretic peptide levels in patients with heart failure at hospital discharge.
    Oral I; Mistrík J; Náplava R
    Herz; 2007 Oct; 32(7):583-8. PubMed ID: 17972033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The natriuretic peptides in cardiovascular medicine.
    Munagala VK; Burnett JC; Redfield MM
    Curr Probl Cardiol; 2004 Dec; 29(12):707-69. PubMed ID: 15550914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure.
    Gallegos PJ; Maclaughlin EJ; Haase KK
    Pharmacotherapy; 2008 Mar; 28(3):343-55. PubMed ID: 18294114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Natriuretic peptides, renal impairment and onset of cardiovascular complications].
    Pudil R; Tichý M
    Vnitr Lek; 2009 Oct; 55(10):913-4. PubMed ID: 19947232
    [No Abstract]   [Full Text] [Related]  

  • 33. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence.
    Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM
    Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The natriuretic peptides in heart failure.
    Richards AM
    Basic Res Cardiol; 2004 Mar; 99(2):94-100. PubMed ID: 14963668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac biomarkers and survival in haemodialysis patients.
    Sommerer C; Beimler J; Schwenger V; Heckele N; Katus HA; Giannitsis E; Zeier M
    Eur J Clin Invest; 2007 May; 37(5):350-6. PubMed ID: 17461980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasma brain natriuretic peptide levels in the diagnostic and prognostic assessment of patients with heart failure. Pros].
    Metra M; Nodari S; Pedrinazzi C; Rocca P; Manerba A; Vizzardi E; Danesi R; Dei Cas L
    Ital Heart J; 2003 Dec; 4 Suppl 8():59S-67S. PubMed ID: 15005534
    [No Abstract]   [Full Text] [Related]  

  • 40. Brain natriuretic peptide: diagnostic and therapeutic implications in pulmonary arterial hypertension.
    Hargett CW; Tapson VF
    Semin Respir Crit Care Med; 2005 Aug; 26(4):385-93. PubMed ID: 16121315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.